CN101684112A - Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof - Google Patents
Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof Download PDFInfo
- Publication number
- CN101684112A CN101684112A CN200810161468A CN200810161468A CN101684112A CN 101684112 A CN101684112 A CN 101684112A CN 200810161468 A CN200810161468 A CN 200810161468A CN 200810161468 A CN200810161468 A CN 200810161468A CN 101684112 A CN101684112 A CN 101684112A
- Authority
- CN
- China
- Prior art keywords
- reaction
- preparation
- compound
- scutellarin
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- URSUMOWUGDXZHU-UHFFFAOYSA-N 4',5,6,7-tetramethoxyflavone Chemical class C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C=C2O1 URSUMOWUGDXZHU-UHFFFAOYSA-N 0.000 title abstract description 36
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 title abstract description 21
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 title abstract description 21
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 title abstract description 19
- 229930190376 scutellarin Natural products 0.000 title abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 42
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 claims abstract description 7
- GVSPXQVUXHMUMA-MDWZMJQESA-N (e)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)\C=C\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GVSPXQVUXHMUMA-MDWZMJQESA-N 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims abstract 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229940126214 compound 3 Drugs 0.000 claims description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 6
- 150000002170 ethers Chemical class 0.000 claims description 6
- 229940125904 compound 1 Drugs 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 4
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- -1 2-hydroxyl-4,5,6-trimethoxy methyl phenyl Chemical group 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 229940125782 compound 2 Drugs 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 150000003138 primary alcohols Chemical class 0.000 claims description 2
- 150000003333 secondary alcohols Chemical class 0.000 claims description 2
- 150000003509 tertiary alcohols Chemical class 0.000 claims description 2
- 235000014493 Crataegus Nutrition 0.000 claims 2
- 241001092040 Crataegus Species 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 229930003944 flavone Natural products 0.000 claims 2
- 150000002213 flavones Chemical class 0.000 claims 2
- 235000011949 flavones Nutrition 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 1
- 150000001788 chalcone derivatives Chemical class 0.000 claims 1
- 229930182478 glucoside Natural products 0.000 claims 1
- 150000008131 glucosides Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 14
- 238000007243 oxidative cyclization reaction Methods 0.000 abstract description 3
- 239000000543 intermediate Substances 0.000 description 12
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 9
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007039 two-step reaction Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VTCDZPUMZAZMSB-UHFFFAOYSA-N 3,4,5-trimethoxyphenol Chemical compound COC1=CC(O)=CC(OC)=C1OC VTCDZPUMZAZMSB-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 2
- 241001013934 Erigeron breviscapus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 235000005513 chalcones Nutrition 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- AUBSOXOLXBPJBL-UHFFFAOYSA-N 2,2,2-trimethoxy-1-phenylethanone Chemical compound COC(OC)(OC)C(=O)C1=CC=CC=C1 AUBSOXOLXBPJBL-UHFFFAOYSA-N 0.000 description 1
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
技术领域 technical field
本发明涉及化合物制备工艺,具体涉及灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的制备方法。The invention relates to a compound preparation process, in particular to a preparation method of scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone.
背景技术 Background technique
灯盏花又名灯盏细辛,属菊豆科短亭飞蓬类植物。灯盏花素是从灯盏花全株植物中分离提取出的以含灯盏花乙素为主(>90%),还含有少量灯盏花甲素的混合物,灯盏花乙素又称野黄芩苷。灯盏花素具有活血化瘀、散寒解表、舒筋活络、祛风除湿之功效,临床上常用于治疗心脑血管疾病。Erigeron breviscapus, also known as Erigeron breviscapus, belongs to the genus Fabaceae. The scutellarin is isolated and extracted from the whole plant of breviscapine, mainly containing scutellarin (>90%), and also contains a small amount of scutellarin, which is also called scutellarin. Breviscapine has the effects of promoting blood circulation and removing blood stasis, dispelling cold and relieving the surface, relaxing tendons and activating collaterals, expelling wind and dampness, and is often used clinically to treat cardiovascular and cerebrovascular diseases.
5,6,7,4’-四甲氧基黄酮是制备心血管药物灯盏花乙素以及灯盏花乙素甙元的重要中间体(崔建梅等,《天然产物研究与开发》,2003,15(3):255-258),目前报道的制备方法有下列两种:5,6,7,4'-tetramethoxyflavone is an important intermediate for the preparation of cardiovascular drugs scutellarin and scutellarin aglycone (Cui Jianmei et al., "Natural Product Research and Development", 2003, 15( 3): 255-258), the preparation method reported at present has following two kinds:
1)3,4,5-三甲氧基苯酚和对甲氧基苯炔酸在五氧化二磷和甲磺酸作用下缩合制得。该方法虽然仅一步反应,但是反应原料对甲氧基苯炔酸较难获得,也不易制备。同时,该步缩合反应的收率极低,仅5%左右,不具有应用价值。1) It is prepared by condensation of 3,4,5-trimethoxyphenol and p-methoxybenzoic acid under the action of phosphorus pentoxide and methanesulfonic acid. Although the method only has one-step reaction, the reaction raw material p-methoxyphenynoic acid is difficult to obtain and difficult to prepare. Simultaneously, the yield of this step condensation reaction is extremely low, only about 5%, does not have application value.
2)2-羟基-4,5,6-三甲氧基苯乙酮为原料,首先与对甲氧基苯甲酰氯反应生成酚酯,然后在碱性条件下该酚酯进行Baker-Venkatamah重排反应得到酚芳基二酮,其在HOAc-NaOAc条件下加热即环合制得5,6,7,4’-四甲氧基黄酮。该方法经过三步反应操作,每步反应的收率也不错,但操作要求较繁琐。2) 2-Hydroxy-4,5,6-trimethoxyacetophenone is used as raw material, first reacts with p-methoxybenzoyl chloride to generate phenolic ester, and then the phenolic ester undergoes Baker-Venkatamah rearrangement under alkaline conditions The reaction yields phenol aryl diketone, which is heated under the condition of HOAc-NaOAc to obtain 5,6,7,4'-tetramethoxyflavone through cyclization. The method is operated through three steps of reaction, and the yield of each reaction step is also good, but the operation requirement is more loaded down with trivial details.
发明内容 Contents of the invention
本发明的目的在于提供一种制备灯盏花乙素及其甙元的关键中间体5,6,7,4’-四甲氧基黄酮的新方法,该方法操作步骤简单,产品收率高。The object of the present invention is to provide a new method for preparing 5,6,7,4'-tetramethoxyflavone, the key intermediate of scutellarin and its aglycone, the method has simple operation steps and high product yield.
本发明的灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的制备方法,是以化合物2所示的2-羟基-4,5,6-三甲氧基苯乙酮为原料,通过反应a和反应b两步制备而成,其中反应a是由2-羟基-4,5,6-三甲氧基苯乙酮与对甲氧基苯甲醛缩合制得化合物3所示的查耳酮衍生物,反应b是将该查耳酮衍生物氧化环合后制得化合物1所示的5,6,7,4’-四甲氧基黄酮,化学反应式如下:The preparation method of scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone of the present invention is based on the 2-hydroxyl-4,5,6-trimethyl Oxyacetophenone is used as a raw material and prepared in two steps through reaction a and reaction b, wherein reaction a is prepared by condensation of 2-hydroxy-4,5,6-trimethoxyacetophenone and p-methoxybenzaldehyde To obtain the chalcone derivative shown in compound 3, reaction b is to prepare the 5,6,7,4'-tetramethoxyflavone shown in compound 1 after the oxidative cyclization of the chalcone derivative, the chemical reaction The formula is as follows:
化合物2 化合物3 化合物1Compound 2 Compound 3 Compound 1
其中,在反应a中的反应溶剂选自低级醇类、醚类或烃类溶剂,可以是其中的一种或任意组合。Wherein, the reaction solvent in reaction a is selected from lower alcohols, ethers or hydrocarbon solvents, and may be one or any combination thereof.
低级醇包括C6以下的一级醇、二级醇或三级醇,如甲醇、乙醇等;醚类溶剂中可以是简单醚或混合醚,如四氢呋喃、二氧六环等;常见烃类溶剂选自烷烃、烯烃、炔烃、环烷烃、环烯烃或芳香烃。Lower alcohols include primary alcohols below C6, secondary alcohols or tertiary alcohols, such as methanol, ethanol, etc.; ether solvents can be simple ethers or mixed ethers, such as tetrahydrofuran, dioxane, etc.; common hydrocarbon solvents From alkanes, alkenes, alkynes, cycloalkanes, cycloalkenes or aromatics.
其中,反应a的反应温度为20-100℃;催化剂包括无机酸(如盐酸、硫酸等)、有机酸(如对甲苯磺酸等)或无机碱(如氢氧化钾、氢氧化钠等)或有机碱(如吡啶、三乙胺等)。Wherein, the reaction temperature of reaction a is 20-100 DEG C; Catalyst comprises inorganic acid (such as hydrochloric acid, sulfuric acid etc.), organic acid (such as p-toluenesulfonic acid etc.) or inorganic base (such as potassium hydroxide, sodium hydroxide etc.) or Organic bases (such as pyridine, triethylamine, etc.).
其中,对甲氧基苯甲醛和2-羟基-4,5,6-三甲氧基苯乙酮用量比为1-2.5∶1。Wherein, the dosage ratio of p-methoxybenzaldehyde and 2-hydroxyl-4,5,6-trimethoxyacetophenone is 1-2.5:1.
其中,反应b中的反应溶剂可以是二甲基亚砜、醇类(乙二醇、丙二醇等)、烃类(甲苯、二甲苯等)、醚类(二氧六环等)或N,N-二甲基甲酰胺(DMF)等其它常见溶剂;反应试剂为二甲基亚砜与无机碘或其金属盐的混合物;反应温度为80-200℃。Wherein, the reaction solvent in reaction b can be dimethyl sulfoxide, alcohols (ethylene glycol, propylene glycol, etc.), hydrocarbons (toluene, xylene, etc.), ethers (dioxane, etc.) or N, N - other common solvents such as dimethylformamide (DMF); the reaction reagent is a mixture of dimethyl sulfoxide and inorganic iodine or its metal salt; the reaction temperature is 80-200°C.
本发明提供了一种新的合成灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的方法,该方法经两步反应制得,操作步骤简单,产品收率高,具有较好的应用价值。本发明的实施例1和实施例2的反应收率均为85%左右,两步反应总的反应收率为72%左右,和现有技术中制备灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的方法相比,不仅显著超出一步反应法(约为5%左右),而且明显高于文献报道三步反应法的总收率(约为60%左右)。The invention provides a new method for synthesizing scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone, which is prepared by two-step reaction, and the operation steps are simple. The product yield is high and has good application value. The reaction yields of Example 1 and Example 2 of the present invention are both about 85%, and the total reaction yield of the two-step reaction is about 72%, which is the same as that in the prior art for preparing scutellarin and its aglycon key intermediates Compared with the method of 5,6,7,4'-tetramethoxyflavone, it not only significantly exceeds the one-step reaction method (about 5%), but also is obviously higher than the total yield of the three-step reaction method reported in the literature (about 5%). around 60%).
具体实施方式 Detailed ways
下面通过实施例具体说明本发明所述的灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的制备方法。本发明中原料(2-羟基-4,5,6-三甲氧基苯乙酮)按照文献报道方法(段新方等,《有机化学》,2003,23(4):353-355)制备。The preparation method of scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone described in the present invention will be specifically illustrated by the following examples. The raw material (2-hydroxy-4,5,6-trimethoxyacetophenone) in the present invention is prepared according to the method reported in the literature (Duan Xinfang et al., "Organic Chemistry", 2003, 23(4): 353-355).
实施例1:查耳酮(化合物3)的制备Embodiment 1: the preparation of chalcone (compound 3)
称取11.3g(0.05mol)化合物2,2-羟基-4,5,6-三甲氧基苯乙酮7.4g(0.06mol)对甲氧基苯甲醛置于250ml圆底烧瓶中,加入150ml甲醇和22.5g固体KOH,室温下搅拌反应36小时。减压蒸去大部分甲醇后加入200ml水,然后用浓盐酸调至PH3-4。析出红色沉淀,充分放置后过滤,沉淀用少许水洗涤,压干,60℃干燥即得。实施例1是本发明制备灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的第一步反应,是由2-羟基-4,5,6-三甲氧基苯乙酮与对甲氧基苯甲醛缩合制得查耳酮衍生物(化合物3),第一步反应得化合物3干燥品14.5克,反应收率在85%左右。1HNMR(CDCl3):δ13.80(s,1H),δ7.87(s,1H),δ7.86(s,1H),δ7.62(d,J=8.5Hz,2H),δ6.96(d,J=8.5Hz,2H),δ6.31(s,1H),δ3.94(s,3H),δ3.92(s,3H),δ3.88(s,3H),δ3.86(s,3H)。MS(m/e):344。Weigh 11.3g (0.05mol) of the compound 2,2-hydroxy-4,5,6-trimethoxyacetophenone and 7.4g (0.06mol) of p-methoxybenzaldehyde in a 250ml round bottom flask, add 150ml of methanol and 22.5 g of solid KOH, stirred and reacted at room temperature for 36 hours. After most of the methanol was distilled off under reduced pressure, 200ml of water was added, and then the pH was adjusted to 3-4 with concentrated hydrochloric acid. Precipitate a red precipitate, put it well and filter it, wash the precipitate with a little water, press dry, and dry at 60°C. Example 1 is the first step reaction of the present invention to prepare scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone, which is obtained from 2-hydroxy-4,5,6- The chalcone derivative (compound 3) was prepared by condensation of trimethoxyacetophenone and p-methoxybenzaldehyde. The first step reacted to obtain 14.5 g of compound 3 dry product, and the reaction yield was about 85%. 1HNMR (CDCl3): δ13.80 (s, 1H), δ7.87 (s, 1H), δ7.86 (s, 1H), δ7.62 (d, J=8.5Hz, 2H), δ6.96 ( d, J=8.5Hz, 2H), δ6.31(s, 1H), δ3.94(s, 3H), δ3.92(s, 3H), δ3.88(s, 3H), δ3.86( s, 3H). MS (m/e): 344.
实施例2:5,6,7,4’-四甲氧基黄酮(化合物1)的制备Embodiment 2: the preparation of 5,6,7,4'-tetramethoxyflavone (compound 1)
称取17.2g(0.05mol)化合物A9置于250ml圆底烧瓶中,加入50mlDMSO和少许碘粒,加热至回流反应30min,则将反应液稍放冷,加入100ml冷水,充分搅拌,过滤即得化合物A7,为类白色结晶。实施例2是本发明制备灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的第二步反应,是将实施例1制得的查耳酮衍生物(化合物3)氧化环合后即制得5,6,7,4’-四甲氧基黄酮,第二步反应得到化合物1干燥品14.6克,反应收率在85%左右。1HNMR(CDCl3):δ7.83(d,J=9.0Hz,2H),δ7.01(d,J=9.0Hz,2H),δ6.81(s,1H),δ6.59(s,1H),δ4.00(s,3H),δ3.99(s,3H),δ3.93(s,3H),δ3.89(s,3H)。MS(m/e):342。Weigh 17.2g (0.05mol) of compound A9 into a 250ml round bottom flask, add 50ml of DMSO and a little iodine, heat to reflux for 30min, then let the reaction solution cool down, add 100ml of cold water, stir well, and filter to obtain the compound A7 is off-white crystal. Example 2 is the second step reaction of the present invention to prepare scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone, which is derived from the chalcone prepared in Example 1 5,6,7,4'-tetramethoxyflavone was obtained after oxidative cyclization of compound (compound 3). In the second step, 14.6 g of dry product of compound 1 was obtained, and the reaction yield was about 85%. 1 HNMR (CDCl 3 ): δ7.83(d, J=9.0Hz, 2H), δ7.01(d, J=9.0Hz, 2H), δ6.81(s, 1H), δ6.59(s, 1H), δ4.00(s, 3H), δ3.99(s, 3H), δ3.93(s, 3H), δ3.89(s, 3H). MS (m/e): 342.
以上两个实施例说明了本发明制备灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的两步反应,操作步骤简单。其中,两步反应的收率均为85%左右,因此总的反应收率为85%×85%≈72%,和现有技术中制备灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的方法相比,不仅显著超出一步反应(约为5%左右),而且明显高于文献报道三步反应法的总收率(约为60%左右)。The above two examples illustrate the two-step reaction of the present invention for preparing scutellarin and its aglycone key intermediate 5,6,7,4'-tetramethoxyflavone, and the operation steps are simple. Among them, the yield of the two-step reaction is about 85%, so the total reaction yield is 85% × 85% ≈ 72%, and the preparation of scutellarin and its aglycon key intermediates in the prior art 5,6 , compared with the method of 7,4'-tetramethoxyflavone, it not only significantly exceeds the one-step reaction (about 5%), but also obviously higher than the total yield of the three-step reaction method reported in the literature (about 60%) .
以上对本发明所提供的灯盏花乙素及其甙元关键中间体5,6,7,4’-四甲氧基黄酮的制备方法进行了详细描述。需要指出的是,具体实施方式所描述的内容是为更好的实施本发明而优选的实施方式,本发明的保护范围不限于上述实施方式所述的技术方案,而应以权利要求书所述的实质内容为准,任何可能的组成、含量及工艺上的改变只要不脱离本发明权利要求的实质内容均属于本发明所保护的范围。The preparation method of scutellarin and its aglycon key intermediate 5,6,7,4'-tetramethoxyflavone provided by the present invention has been described in detail above. It should be pointed out that the content described in the specific embodiments is a preferred embodiment for better implementing the present invention, and the protection scope of the present invention is not limited to the technical solutions described in the above embodiments, but should be described in the claims. The essential content of the present invention shall prevail, and any possible changes in composition, content and process shall fall within the protection scope of the present invention as long as they do not deviate from the essential content of the claims of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810161468A CN101684112A (en) | 2008-09-27 | 2008-09-27 | Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810161468A CN101684112A (en) | 2008-09-27 | 2008-09-27 | Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101684112A true CN101684112A (en) | 2010-03-31 |
Family
ID=42047520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810161468A Pending CN101684112A (en) | 2008-09-27 | 2008-09-27 | Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101684112A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014015625A1 (en) * | 2012-07-23 | 2014-01-30 | 昆明制药集团股份有限公司 | Method for preparing high purity scutellarin aglycone |
CN105218606A (en) * | 2015-10-19 | 2016-01-06 | 昆明理工大学 | A kind of method preparing scutellarin |
CN105439876A (en) * | 2014-09-19 | 2016-03-30 | 四川大学 | 2-hydroxychalcone amine compounds, and preparation method and uses thereof |
CN105906600A (en) * | 2016-05-20 | 2016-08-31 | 昆明理工大学 | Method for preparing scutellarin |
CN107759646A (en) * | 2016-08-22 | 2018-03-06 | 昆明龙津药业股份有限公司 | A kind of synthetic method of lamp-dish flower acetic |
-
2008
- 2008-09-27 CN CN200810161468A patent/CN101684112A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014015625A1 (en) * | 2012-07-23 | 2014-01-30 | 昆明制药集团股份有限公司 | Method for preparing high purity scutellarin aglycone |
CN105439876A (en) * | 2014-09-19 | 2016-03-30 | 四川大学 | 2-hydroxychalcone amine compounds, and preparation method and uses thereof |
CN105439876B (en) * | 2014-09-19 | 2017-11-07 | 四川大学 | 2 hydroxylated chalcone aminated compounds, preparation method and use |
CN105218606A (en) * | 2015-10-19 | 2016-01-06 | 昆明理工大学 | A kind of method preparing scutellarin |
CN105218606B (en) * | 2015-10-19 | 2017-12-01 | 昆明理工大学 | A kind of method for preparing scutellarin |
CN105906600A (en) * | 2016-05-20 | 2016-08-31 | 昆明理工大学 | Method for preparing scutellarin |
CN107759646A (en) * | 2016-08-22 | 2018-03-06 | 昆明龙津药业股份有限公司 | A kind of synthetic method of lamp-dish flower acetic |
CN107759646B (en) * | 2016-08-22 | 2021-07-27 | 昆明龙津药业股份有限公司 | Method for synthesizing scutellarin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102267985B (en) | The preparation method of vilazodone or its hydrochloride | |
RU2397981C2 (en) | 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide synthesis method | |
CN101684112A (en) | Preparation method of 5,6,7,4'-tetramethoxy flavones of scutellarin and aglucone key intermediate thereof | |
JP7368636B2 (en) | Method for synthesizing roxadustat and its intermediates and intermediates thereof | |
CN111925381A (en) | Synthesis method of baroxavir key intermediate | |
CN102307859A (en) | Process for the synthesis of cleistanthin | |
CN113735847A (en) | Synthetic preparation method of berberine hydrochloride | |
CN101381291B (en) | A method for preparing 2,3,4,5-tetramethoxytoluene | |
CN101085769B (en) | A kind of synthetic method of α-pyrone derivatives | |
Fukui et al. | Synthetic studies of the flavone derivatives. VII. The synthesis of jaceidin | |
CN116803986B (en) | A kind of synthesis method of roxadustat intermediate | |
CN106866608A (en) | A kind of preparation method of the dihydrocoumarin derivative of fluoro 3,4 | |
CN101805380B (en) | Method for preparing (3S, 5S)-2, 3-dihydroxyl-5-hydroxymethyl tetrahydrofuran triacetate | |
CN109694311B (en) | A kind of synthetic method of isoliquiritigenin | |
CN102086147B (en) | Preparation method of substituted phenol | |
WO2022099930A1 (en) | Preparation method for cannflavin compounds | |
CN110818694B (en) | Esalapu Lin Zhongjian body and application thereof | |
CN110724135B (en) | Esalapril Lin Zhongjian body and preparation method thereof | |
CN110642792B (en) | Preparation method of ilaprine intermediate | |
CN110713483A (en) | Elaprepilin intermediate and preparation method of elaprilin | |
CN110746361B (en) | Esalapril Lin Zhongjian body and preparation method thereof | |
CN111233951A (en) | Preparation method of orcinol glucoside | |
WO2022117071A1 (en) | Method for synthesizing benzyl ether from polyhydric phenol | |
Chen et al. | Synthesis of 8-Halogenoflavones1 | |
CN116135848B (en) | A coumarin compound and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20100331 |